Vanda Pharmaceuticals, Inc. (VNDA)
6.11
+0.17
(+2.86%)
USD |
NASDAQ |
Jun 09, 16:00
6.11
0.00 (0.00%)
After-Hours: 18:31
Vanda Pharmaceuticals SG&A Expense (Quarterly) : 68.36M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 163.90M |
| AnaptysBio, Inc. | 26.20M |
| Incyte Corp. | 328.09M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |